Division of Clinical, Social and Administrative Sciences

Faculty

Henry Freedy, Pharm.D. Associate Professor of Pharmacy Practice T 412.232.8323 hfreedy@mercy.pmhs.org

Educational Background

B.S. (Pharmacy)--Duquesne University
Pharm.D., --Duquesne University

Courses Taught

• PHBMS 426--Biomedical Sciences & Therapeutics V (Coursemaster)
• PHINT 491--Integrated Case Studies (Coursemaster)
• NTDP--Infectious Disease Module
• Preceptor, Clinical Clerkship/Elective Experiential
• Education--Infectious Disease

Recent Presentations

• "The ATS Guidelines and the Management of Community Acquired Pneumonia Medical Grand Rounds," Camden Clark Hospital, Parkersburg, W.Va., January 8.
• "New Agents for the Management of CAP," United Community Hospital Spring Seminar,
• "New Agents for the Management of CAP," PSHP Mid-Year Conference, Pittsburgh, PA, March 19, 1999.
• "Treatment of CAP in the Era of PRSP," Lock Haven University Physicians Assistant Program, Lock Haven, PA, February 11, 1999.
• "The Role of the New Fluoroquinolones in the Management of CAP," Jefferson County Academy of Pharmacy, Steubenville, OH, January 28, 1999.
• "Macrolides in the Treatment of CAP in the Era PRSP," Newark Wayne Hospital Medical Grand Rounds, Newark, NJ, November 20, 1998.
• "The Place of Macrolides in the Management of Respiratory Tract Infection," Belmont County Medical Society Monthly Meeting, St. Clairsville, OH, October 15, 1998.
• "Controlling Antibiotic Use in the Era of Resistance," Association for Professionals in Infection Control and Epidemiology (APIC), Three Rivers Chapter. Symposium Titled "Infection Issues Entering the 21st Century," Radisson Hotel, Monroeville, PA, October 2, 1998.
• "An Overview of the New Fluoroquinolones," St. Clair Hospital Medical Staff CE Conference St. Clair Hospital, Pgh., PA, September 10, 1998.
  "An Overview of the New Fluoroquinolones," Eastern Ohio Assoc. Family Practice Physicians, Quarterly CE Meeting. Columbus, OH, September 3, 1998.
• "The Management of CAP," Carbondale Medical Society Quarterly Meeting, Carbondale, IL, April 28, 1998.
• "An Update on New Antibiotics," Good Samaritan Hospital Medical Staff CE Conference, Good Samaritan Hospital, Johnstown, PA, April 14, 1998.
• "The Management of CAP," Western Chapter, Pennsylvania Society Hospital Pharmacists, Pittsburgh, PA, March 26, 1998.
• "Winning the Battle and Losing the War Against Drug Resistant Organisms," Association for Professionals in Infection Control and Epidemiology (APIC) Eastern Ohio - Western PA Chapter. Symposium Title "New Drug News: Current Infectious Disease Topics for Health Care Settings."

Recent Grants

• $400.00 from Merck & Co. for "Investigate the Potential Inactivation of Amikacin by Imipenem,", September 1998.
• $1000.00 from Pfizer, Inc. for "In Vitro Study of Trovafloxacin and Ciprofloxacin Against Ps. aeruginosa and Other Non-Fermenting Gram-Negative Rods," in cooperation with Spyros Kominos, Sc.D., Clinical Microbiologist.